| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |